ClinConnect ClinConnect Logo
Search / Trial NCT04289324

Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants

Launched by MEDICAL UNIVERSITY OF VIENNA · Feb 26, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help extremely preterm infants breathe better while they are on a specific type of ventilation called High Frequency Oscillatory Ventilation (HFOV). The researchers want to see if a method that involves adjusting the lung settings based on oxygen levels can improve how well these infants are getting oxygen. The goal is to lower a measurement called the oxygen saturation index (OSI), which helps doctors understand how effectively the lungs are working.

To be eligible for this study, infants must be born before 28 weeks of pregnancy and not older than 29 weeks of postmenstrual age. They should be receiving HFOV for their breathing support. However, infants with certain heart, lung, or brain problems, or those with specific genetic conditions, cannot participate. If eligible, parents can expect their infants to be closely monitored during the trial, and their healthcare team will provide information and support throughout the process.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Preterm infants
  • born below 28 weeks of gestational age
  • not older than 29 weeks of postmenstrual age
  • receive HFOV
  • Exclusion Criteria:
  • known congenital anomalies of the heart, of the lung, and/or of the central nervous system
  • known chromosomal abnormalities
  • participation in other intervention trials

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Tobias Werther

Principal Investigator

Medical University of Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials